ArticleScientific reports2026
Diagnosis and grading of steatotic liver disease via clinical and laboratory data using machine learning.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Steatotic liver disease (SLD) is one of the most common chronic liver conditions worldwide and may lead to severe complications if not diagnosed and managed promptly. Its high spread, particularly in the MENA region, highlights the urgent need for early, accessible, and cost-effective diagnostic strategies. While conventional diagnostic methods such as imaging and biopsy offer high accuracy, they are invasive, costly, and impractical for large-scale screening efforts. In contrast, clinical and laboratory data represent a non-invasive, readily available, and inexpensive alternative for SLD detection. In this study, a machine learning-based approach was developed to diagnose and grade SLD using such routinely collected clinical and biochemical features. Various machine learning algorithms were applied, with SVM-XGBOOST achieving an accuracy of 90% using only eight features. Following expert consultation with gastroenterologists, four clinically relevant features, including Ferritin, Fasting Blood Glucose, Triglycerides, and Body Mass Index, were identified. Using these four features alone, the model retained a classification accuracy of 70%. These findings indicate that the integration of machine learning techniques with clinical and laboratory data can substantially improve diagnostic accuracy and efficiency. This approach offers a scalable and non-invasive solution for SLD screening, particularly in resource-limited or underserved healthcare settings, thereby facilitating early detection and timely intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.